Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07195604
PHASE1

A Single Ascending Dose of HRS-2162 in Healthy Subjects

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

The study is being conducted to evaluate the safety and tolerability of HRS-2162 injection in a single dose in healthy subjects, as well as the characteristics of PK/PD

Official title: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of HRS-2162 Injection in Healthy Subjects

Key Details

Gender

All

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

64

Start Date

2025-09-25

Completion Date

2025-12

Last Updated

2025-11-17

Healthy Volunteers

Yes

Interventions

DRUG

HRS-2162

HRS-2162

DRUG

Placebo

Placebo

Locations (1)

Sichuan Academy of Medical Sciences &Sichuan Provincial People's Hospital

Chengdu, Sichuan, China